SILVERARC CAPITAL MANAGEMENT, LLC – Vertex Pharmaceuticals Incorporated Transaction History
SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:
$3.21M
portfolio value
SILVERARC CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +6.64% | 691 shares | 280K | $289.54 | 11.10K |
Q2 2022 | share | Increase | +36.34% | 2.77K shares | 942K | $281.79 | 10.41K |
Q1 2022 | share | Increase | +52.76% | 2.63K shares | 895K | $260.97 | 7.63K |
Q4 2021 | share | Increase | 0.00% | 5K shares | 1.09M | $222.45 | 5K |
Q2 2021 | share | Decrease | -100.00% | -7.5K shares | -1.61M | $201.63 | 0 |
Q1 2021 | share | Increase | +50.00% | 2.5K shares | 430K | $214.89 | 7.5K |
Q4 2020 | share | Increase | 0.00% | 5K shares | 1.18M | $236.34 | 5K |